A Multicenter, Open-label, Single-arm, Phase II Study of NHWD-870 HCl in Adults and Adolescents with Advanced NUT Cancer

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 25, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

December 30, 2025

Conditions

Advanced Solid Tumor (Phase 1)

Interventions

DRUG

NHWD-870 HCl

Administered P.O.

Trial Locations (1)

RECRUITING

Three Gorges Hospital Affiliated to Chongqing University, Chongqing

All Listed Sponsors

lead

Zhejiang Wenda Medical Technology Co., Ltd.

OTHER